Colorectal Cancer With High Tumor Mutational Burden and Mesenchymal-Epithelial Transition (MET) Amplification With Hyperprogressive Disease After Pembrolizumab Treatment.
Saved in:
| Title: | Colorectal Cancer With High Tumor Mutational Burden and Mesenchymal-Epithelial Transition (MET) Amplification With Hyperprogressive Disease After Pembrolizumab Treatment. |
|---|---|
| Authors: | Nakajima S; Gastroenterology, Tokyo Bay Urayasu Ichikawa Medical Center, Urayasu, JPN., Sasaki A; Gastroenterology, Tokyo Bay Urayasu Ichikawa Medical Center, Urayasu, JPN., Okamoto R; Gastroenterology, Tokyo Bay Urayasu Ichikawa Medical Center, Urayasu, JPN. |
| Source: | Cureus [Cureus] 2025 Jun 13; Vol. 17 (6), pp. e85954. Date of Electronic Publication: 2025 Jun 13 (Print Publication: 2025). |
| Publication Type: | Case Reports; Journal Article |
| Journal Info: | Publisher: Cureus, Inc Country of Publication: United States NLM ID: 101596737 Publication Model: eCollection Cited Medium: Print ISSN: 2168-8184 (Print) Linking ISSN: 21688184 NLM ISO Abbreviation: Cureus Subsets: PubMed not MEDLINE |
| Database: | MEDLINE Ultimate |
|
Full text is not displayed to guests.
Login for full access.
|
|
Be the first to leave a comment!
